Sponsor Pipeline

Myosin Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07185880 A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients Glioblastoma (GBM) Recruiting
NCT07604285 A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients… Glioblastoma Not Yet Recruiting
Disease Areas
Glioblastoma (2)
Get alerts when Myosin Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free